CD248 and its cytoplasmic domain: A therapeutic target for arthritis

Arthritis Care and Research

Volumn 62, Issue 12, 2010, Pages 3595-3606

  Maia, Margarida ^a   De Vriese, Astrid ^a   Janssens, Tom ^a   Moons, Michaël ^a   Van Landuyt, Kristel ^a   Tavernier, Jan ^b   Lories, Rik J ^a   Conway, Edward M ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; ENDOSIALIN; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; PLACENTAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; FIBRINOGEN; MEMBRANE PROTEIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE INJURY; CELL ADHESION; COLLAGEN ANTIBODY INDUCED ARTHRITIS; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; JOINT BIOPSY; KNOCKOUT MOUSE; LEUKOCYTE ADHERENCE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; STAINING; STROMA CELL; SYNOVIAL HYPERPLASIA; SYNOVIUM; TRANSGENIC MOUSE; WILD TYPE; BLOOD LEVEL; EMBRYO; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC ANIMAL;

ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOPSY; CELL ADHESION; CYTOKINES; CYTOPLASM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MIDDLE AGED; PREGNANCY PROTEINS; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649891325     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27701     Document Type: Article

References (47)

1. Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD,. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008; 153 Suppl 1: S241-6.
2. Filer A, Parsonage G, Smith E, Osborne C, Thomas AM, Curnow SJ, et al. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum 2006; 54: 2096-108.
3. Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, Salmon M, et al. A stromal address code defined by fibroblasts. Trends Immunol 2005; 26: 150-6.
4. Luyten FP, Lories RJ, Verschueren P, de Vlam K, Westhovens R,. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol 2006; 20: 829-48.
5. Kiener HP, Watts GF, Cui Y, Wright J, Thornhill TS, Skold M, et al. Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture. Arthritis Rheum 2010; 62: 742-52.
6. Yoo SA, Kwok SK, Kim WU,. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm 2008; 2008: 129873.
7. Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, et al. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 2009; 60: 345-54.
8. Sandler C, Joutsiniemi S, Lindstedt KA, Juutilainen T, Kovanen PT, Eklund KK,. Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts. Biochem Biophys Res Commun 2006; 347: 31-5.
9. Tsai SH, Sheu MT, Liang YC, Cheng HT, Fang SS, Chen CH,. TGF-β inhibits IL-1β-activated PAR-2 expression through multiple pathways in human primary synovial cells. J Biomed Sci 2009; 16: 97.
10. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN,. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1258-65.
11. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ,. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci U S A 1992; 89: 10832-6.
12. MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 2005; 579: 2569-75.
13. Lax S, Hou TZ, Jenkinson E, Salmon M, MacFadyen JR, Isacke CM, et al. CD248/endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair. FEBS Lett 2007; 581: 3550-6.
14. Brady J, Neal J, Sadakar N, Gasque P,. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. J Neuropathol Exp Neurol 2004; 63: 1274-83.
15. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, et al. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94.
16. Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM,. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008; 21: 308-15.
17. Rouleau C, Curiel M, Weber W, Smale R, Kurtzberg L, Mascarello J, et al. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Clin Cancer Res 2008; 14: 7223-36.
18. Carson-Walter EB, Winans BN, Whiteman MC, Liu Y, Jarvela S, Haapasalo H, et al. Characterization of TEM1/endosialin in human and murine brain tumors. BMC Cancer 2009; 9: 417.
19. Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG,. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004; 21: 31-7.
20. Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, et al. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A 2006; 103: 3351-6.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
22. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, and the CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
23. Lallemand Y, Luria B, Haffner-Krausz R, Lonai P,. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res 1998; 7: 105-12.
24. Van de Wouwer M, Plaisance S, De Vriese A, Waelkens E, Collen D, Persson J, et al. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost 2006; 4: 1813-24.
25. Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi HP, Garin-Chesa P, et al. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem 2001; 276: 7408-14.
26. Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ, et al. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 2001; 276: 38795-807.
27. Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK III, Imhof BA, et al. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 2008; 58: 3020-9.
28. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8: 831-40.
29. Gobble RM, Groesch KA, Chang M, Torry RJ, Torry DS,. Differential regulation of human PlGF gene expression in trophoblast and nontrophoblast cells by oxygen tension. Placenta 2009; 30: 869-75.
30. Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM,. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 2009; 11: R64.
31. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci U S A 2007; 104: 17965-70.
32. Stuelten CH, DaCosta Byfield S, Arany PR, Karpova TS, Stetler-Stevenson WG, Roberts AB,. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β. J Cell Sci 2005; 118: 2143-53.
33. Noss EH, Brenner MB,. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008; 223: 252-70.
34. Ritchlin CT,. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2005; 17: 406-12.
35. Robinson H, Kelly S, Pitzalis C,. Basic synovial biology and immunopathology in psoriatic arthritis. J Rheumatol Suppl 2009; 83: 14-6.
36. Greenlee MC, Sullivan SA, Bohlson SS,. CD93 and related family members: their role in innate immunity. Curr Drug Targets 2008; 9: 130-8.
37. Crockard AD, Thompson JM, Malhotra R, McNeill TA,. Increased expression of C1q receptors on neutrophils from inflammatory joint fluids. Immunol Lett 1993; 36: 195-201.
38. Conway EM, Nowakowski B,. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood 1993; 81: 726-33.
39. Nourry C, Grant SG, Borg JP,. PDZ domain proteins: plug and play! Sci STKE 2003; 2003: RE7.
40. Bohlson SS, Zhang M, Ortiz CE, Tenner AJ,. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis. J Leukoc Biol 2005; 77: 80-9.
41. De Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, et al. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 2006; 34: W362-5.
42. Maciejewska Rodrigues H, Jungel A, Gay RE, Gay S,. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Mol Immunol 2009; 47: 12-8.
43. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996; 271: 17629-34.
44. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK,. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003; 102: 1515-24.
45. Kim WU, Kang SS, Yoo SA, Hong KH, Bae DG, Lee MS, et al. Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation. J Immunol 2006; 177: 5727-35.
46. Kong JS, Yoo SA, Kim JW, Yang SP, Chae CB, Tarallo V, et al. Anti-neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis. Arthritis Rheum 2010; 62: 179-90.
47. Westra J, Molema G, Kallenberg CG,. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis-therapeutic implications. Curr Med Chem 2010; 17: 254-63.